Gain Therapeutics Inc (GANX)
2.455
-0.10
(-3.73%)
USD |
NASDAQ |
Jun 03, 16:00
2.455
0.00 (0.00%)
After-Hours: 19:34
Gain Therapeutics Total Liabilities (Quarterly): 5.935M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.935M |
| December 31, 2023 | 6.031M |
| September 30, 2023 | 6.767M |
| June 30, 2023 | 7.168M |
| March 31, 2023 | 6.184M |
| December 31, 2022 | 5.220M |
| September 30, 2022 | 5.663M |
| Date | Value |
|---|---|
| June 30, 2022 | 4.873M |
| March 31, 2022 | 5.771M |
| December 31, 2021 | 4.168M |
| September 30, 2021 | 5.017M |
| June 30, 2021 | 3.964M |
| March 31, 2021 | 3.577M |
| December 31, 2020 | 3.402M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.402M
Minimum
Dec 2020
7.168M
Maximum
Jun 2023
5.267M
Average
5.441M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 51.05B |
| Alpine Immune Sciences Inc (DELISTED) | 40.94M |
| Outlook Therapeutics Inc | 193.26M |
| OptiNose Inc | 182.92M |
| Greenwich LifeSciences Inc | 0.3896M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.58M |
| Shareholders Equity (Quarterly) | 8.642M |